BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2179754)

  • 1. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.
    Walker RG; Kincaid-Smith P
    Nephron; 1990; 54(2):117-21. PubMed ID: 2179754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH; Fisher M; Neale TJ
    N Z Med J; 1990 Mar; 103(886):125-6. PubMed ID: 2320338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study.
    Garin EH; Orak JK; Hiott KL; Sutherland SE
    Am J Dis Child; 1988 Sep; 142(9):985-8. PubMed ID: 3046332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
    Torres VE; Velosa JA; Holley KE; Frohnert PP; Zincke H; Sterioff S
    Mayo Clin Proc; 1984 Mar; 59(3):146-52. PubMed ID: 6369011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis.
    Ponticelli C; Rivolta E
    Am J Nephrol; 1990; 10 Suppl 1():105-9. PubMed ID: 2256469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with cyclosporin of patients with idiopathic nephrotic syndrome.
    Meyrier A
    Springer Semin Immunopathol; 1987; 9(4):441-50. PubMed ID: 3324370
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Brodehl J; Brandis M; Helmchen U; Hoyer PF; Burghard R; Ehrich JH; Zimmerhackl RB; Klein W; Wonigeit K
    Klin Wochenschr; 1988 Nov; 66(22):1126-37. PubMed ID: 3236762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
    Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic focal segmental glomerulosclerosis resistant to ciclosporin-A therapy.
    Dakshinamurty KV; Hariharan S; Date A; Kirubakaran MG
    Nephron; 1988; 48(4):340. PubMed ID: 3362288
    [No Abstract]   [Full Text] [Related]  

  • 10. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.
    Beaufils H; Alphonse JC; Guedon J; Legrain M
    Nephron; 1978; 21(2):75-85. PubMed ID: 673092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N
    Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF; Farine M; Thorner P; Baumal R
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.
    Usta M; Ersoy A; Dilek K; Ozdemir B; Yavuz M; Güllülü M; Yurtkuran M
    J Intern Med; 2003 Mar; 253(3):329-34. PubMed ID: 12603500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL
    Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial remission of resistant nephrotic syndrome after oral galactose therapy.
    Kopač M; Meglič A; Rus RR
    Ther Apher Dial; 2011 Jun; 15(3):269-72. PubMed ID: 21624074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine treatment of nephrotic syndrome in children.
    Brodehl J; Hoyer PF; Oemar BS; Helmchen U; Wonigeit K
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):269-74. PubMed ID: 3381282
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporin and prednisolone: do they prevent recurrence of focal segmental glomerulosclerosis?
    Burke JR; Rigby RJ
    Nephron; 1986; 43(3):236-7. PubMed ID: 3523270
    [No Abstract]   [Full Text] [Related]  

  • 19. Ciclosporin in idiopathic nephrotic syndrome of children.
    Brodehl J; Hoyer PF
    Am J Nephrol; 1989; 9 Suppl 1():61-4. PubMed ID: 2923148
    [No Abstract]   [Full Text] [Related]  

  • 20. [Corticosteroid therapy of compensated intracapillary glomerulonephritis].
    Ratner MIa; Tomilina NA; Samokhina NM
    Klin Med (Mosk); 1982 Apr; 60(4):72-6. PubMed ID: 7098396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.